Medication overuse headache: A focus on analgesics, ergot alkaloids and triptans

被引：24

作者：

Katsarawa Z. ^{[1
]}

Diener H. ^{[1
]}

Limmroth V. ^{[1
]}

机构：

[1] Department of Neurology, University Hospital Essen, University of Essen, 45122 Essen

来源：

Drug Safety | 2001年 / 24卷 / 12期

关键词：

Migraine; Sumatriptan; Zolmitriptan; Chronic Daily Headache; International Headache Society;

D O I：

10.2165/00002018-200124120-00005

中图分类号：

学科分类号：

摘要：

Medication overuse headache (MOH, formerly known as drug-induced headache) is a well known disorder following the frequent use of analgesics or any other antiheadache drug including serotonin 5-HT1B/D agonists (triptans). Recent studies suggest clinical features of MOH depend on the substance class that has been overused. The delay between the frequent intake of any antiheadache drug and daily headache is shortest for triptans (mean1.7 years), longer for ergot alkaloids (mean 2.7 years) and longest for analgesics (mean 4.9 years). Treatment includes withdrawal followed by structured acute therapy and initiation of specific prophylactic treatment for the underlying primary headache. The relapse rate within 6 months after successful withdrawal is about 30% and increases steadily up to 50% after 5 years.

引用

页码：921 / 927

页数：6

共 46 条

[1]

Peters G.A., Horton B.T., Headache: With special reference to exessive use of ergotamine preparations and withdrawl effects, Mayo Clin Proc, 26, pp. 214-226, (1951)

[2]

Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain, Cephalalgia, 8, pp. 1-96, (1988)

[3]

Diener H.C., Wilkinson M., Drug-induced headache, (1988)

[4]

Kaube H., May A., Pfaffenrath V., Et al., Sumatriptan misuse in daily chronic headache, BMJ, 308, pp. 1573-1574, (1994)

[5]

Limmroth V., Kazarawa S., Fritsche G., Et al., Headache after frequent use of serotonin agonists zolmitriptan naratriptan, Lancet, 353, (1999)

[6]

Castillo J., Munoz P., Guitera V., Et al., Epidemiology of chronic dally headache in the general population, Headache, 39, pp. 190-196, (1999)

[7]

Wang S.J., Fuh J.L., Lu S.R., Et al., Chronic daily headache in Chinese elderly: Prevalence, risk factors, and biannual follow-up, Neurology, 54, pp. 314-319, (2000)

[8]

Robinson R.G., Pain relief for headaches. Is self-medication a problem?, Can Fam Physician, 39, pp. 867-868, (1993)

[9]

Granella F., Farina S., Malferrari G., Et al., Drug abuse in chronic headache: A clinico-epidemiologic study, Cephalalgia, 7, pp. 15-19, (1987)

[10]

Micieli G., Manzoni G.C., Granella F., Et al., Clinical and epidemiological observations on drug abuse in headache patients, MOH, pp. 20-28, (1988)

← 1 2 3 4 5 →